Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fanhdi in pediatric severe von Willebrand disease
2012-003450-92Phase 4Completed
- Sponsor
- Instituto Grifols
- Start
- Nov 2012
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of von willebrand factor + factor viii in von Willebrand disease (VWD), sponsored by Instituto Grifols. Primary endpoint: Pharmacokinetics of von Willebrand factor and factor VIII. Started Nov 2012; status: completed.
02
Drugs
von willebrand factor + factor viii
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on 2012-003450-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003450-92.